Dr. Silvi Shah Honored with 2024 Dr. Nanette K. Wenger Research Goes Red Award
TL;DR
Dr. Silvi Shah's research reveals higher cardiovascular risks for women with kidney failure, providing a competitive advantage in better understanding and treating heart disease in women.
Dr. Shah's study analyzed Medicare claims data for adults receiving dialysis, finding that women with kidney failure had higher risks of cardiovascular events but lower risk of cardiovascular death.
Dr. Shah's research aims to improve cardiovascular care for women with kidney disease, promoting healthier living and reducing the gap in care and outcomes for women's health.
Dr. Silvi Shah has been selected for the 2024 Dr. Nanette K. Wenger Research Goes Red® Award at the American Heart Association's Scientific Sessions 2024, recognizing her groundbreaking research on women's cardiovascular health.
Found this article helpful?
Share it with your network and spread the knowledge!

The American Heart Association has announced Dr. Silvi Shah as the recipient of the 2024 Dr. Nanette K. Wenger Research Goes Red® Award, recognizing her significant contribution to cardiovascular research in women. Dr. Shah, an associate professor at the University of Cincinnati College of Medicine, will be honored at the AHA's Scientific Sessions 2024 in Chicago for her groundbreaking study on sex differences in cardiovascular outcomes among patients with kidney failure.
Dr. Shah's award-winning research, published in the Journal of the American Heart Association, analyzed Medicare claims data from over 500,000 adults receiving dialysis for end-stage kidney disease. The study revealed that women with kidney failure face higher risks of cardiovascular events, including heart failure and stroke, compared to their male counterparts. Paradoxically, these women showed a lower risk of cardiovascular death. These findings underscore the urgent need for healthcare providers to reassess their approach to prevention, education, and promotion of healthy living for women with end-stage kidney disease on dialysis.
The implications of Dr. Shah's research are far-reaching. It highlights significant gaps in understanding women's cardiovascular health, particularly in the context of kidney disease. This knowledge is crucial for developing more effective, gender-specific strategies for prevention and treatment. The study's outcomes suggest that current approaches to cardiovascular care for women with kidney failure may be inadequate and require reevaluation.
Dr. Keith Churchwell, the American Heart Association's 2024-2025 volunteer president, emphasized the importance of Dr. Shah's work in addressing the lack of research on women's health, especially during pregnancy. This research is vital in reducing healthcare disparities and improving health equity for all. The recognition of Dr. Shah's work through this prestigious award underscores the growing emphasis on gender-specific medical research and its potential to transform patient care.
As a nephrologist specializing in women's health, Dr. Shah's commitment to bridging the data gap in women's health research is commendable. Her focus on the intersection of kidney disease, cardiovascular health, and women's unique health needs, particularly during pregnancy, represents a critical area of study with the potential to significantly impact patient outcomes. The award not only recognizes Dr. Shah's achievements but also highlights the importance of continued research in this field to ensure more personalized and effective cardiovascular care for women.
Curated from NewMediaWire


